Effects of the COVID-19 pandemic on supply and use of blood for transfusion

Wise, 2020, A third of covid-19 patients admitted to UK hospitals die, BMJ, 369 Rada, 2020, Evidence synthesis relevant to COVID-19: a protocol for multiple systematic reviews and overviews of systematic reviews, Medwave, 20, 10.5867/medwave.2020.03.7867 Guan, 2020, Clinical characteristics of coronavirus disease 2019 in China, N Engl J Med, 382, 1708, 10.1056/NEJMoa2002032 Richardson, 2020, Presenting characteristics, comorbidities, and outcomes among 5700 patients hospitalized with COVID-19 in the New York City area, JAMA, 323, 2052, 10.1001/jama.2020.6775 Bhatraju, 2020, Covid-19 in critically ill patients in the Seattle region—case series, N Engl J Med, 382, 2012, 10.1056/NEJMoa2004500 Lippi, 2020, Thrombocytopenia is associated with severe coronavirus disease 2019 (COVID-19) infections: a meta-analysis, Clin Chim Acta, 506, 145, 10.1016/j.cca.2020.03.022 Liu, 2020, Consideration and suggestions on development of blood transfusion department under the epidemic situation of novel coronavirus pneumonia, Zhonghua Yi Xue Za Zhi, 100, 1041 Yang, 2020, Thrombocytopenia and its association with mortality in patients with COVID-19, J Thromb Haemost, 18, 1469, 10.1111/jth.14848 Cai, 2020, Blood transfusion during the COVID-19 outbreak, Blood Transfus, 18, 79 Fan, 2020, Blood and blood product use during COVID-19 infection, Am J Hematol, 10.1002/ajh.25823 Berzuini, 2020, Red cell bound antibodies and transfusion requirements in hospitalized patients with COVID-19, Blood, 10.1182/blood.2020006695 Koeckerling, 2020, Blood transfusion strategies and ECMO during the COVID-19 pandemic, Lancet Respir Med, 8, E40, 10.1016/S2213-2600(20)30173-9 Ranucci, 2020, The procoagulant pattern of patients with COVID-19 acute respiratory distress syndrome, J Thromb Haemost, 10.1111/jth.14854 Connors, 2020, COVID-19 and its implications for thrombosis and anticoagulation, Blood, 135, 2033, 10.1182/blood.2020006000 Panigada, 2020, Hypercoagulability of COVID-19 patients in intensive care unit. A report of thromboelastography findings and other parameters of hemostasis, J Thromb Haemost, 10.1111/jth.14850 Cui, 2020, Prevalence of venous thromboembolism in patients with severe novel coronavirus pneumonia, J Thromb Haemost, 18, 1421, 10.1111/jth.14830 Klok, 2020, Incidence of thrombotic complications in critically ill ICU patients with COVID-19, Thromb Res, 191, 145, 10.1016/j.thromres.2020.04.013 Helms, 2020, High risk of thrombosis in patients in severe SARS-CoV-2 infection: a multicentre prospective cohort study, Intensive Care Med, 46, 1089, 10.1007/s00134-020-06062-x Varga, 2020, Endothelial cell infection and endotheliitis in COVID-19, Lancet, 395, 1417, 10.1016/S0140-6736(20)30937-5 Thachil, 2020, ISTH interim guidance on recognition and management of coagulopathy in COVID-19, J Thromb Haemost, 18, 1023, 10.1111/jth.14810 Green, 2018, British Society of Haematology Guidelines on the spectrum of fresh frozen plasma and cryoprecipitate products: their handling and use in various patient groups in the absence of major bleeding, Br J Haematol, 181, 54, 10.1111/bjh.15167 Hunt, 2015, A practical guideline for the haematological management of major haemorrhage, Br J Haematol, 170, 788, 10.1111/bjh.13580 Tang, 2020, Anticoagulant treatment is associated with decreased mortality in severe coronavirus disease 2019 patients with coagulopathy, J Thromb Haemost, 18, 1094, 10.1111/jth.14817 Carson, 2016, Clinical practice guidelines from the AABB: red blood cell transfusion thresholds and storage, JAMA, 316, 2025, 10.1001/jama.2016.9185 Estcourt, 2017, Guidelines for the use of platelet transfusions, Br J Haematol, 176, 365, 10.1111/bjh.14423 Vlachodimitropoulou Koumoutsea, 2020, COVID-19 and acute coagulopathy in pregnancy, J Thromb Haemost, 10.1111/jth.14856 Della Gatta, 2020, Coronavirus disease 2019 during pregnancy: a systematic review of reported cases, Am J Obstet Gynecol, 10.1016/j.ajog.2020.04.013 Breslin, 2020, COVID-19 infection among asymptomatic and symptomatic pregnant women: two weeks of confirmed presentations to an affiliated pair of New York City hospitals, Am J Obstet Gynecol MFM, 2, 10.1016/j.ajogmf.2020.100118 Dai, 2020, ABO blood group predisposes to COVID-19 severity and cardiovascular diseases, Eur J Prev Cardiol, 10.1177/2047487320922370 Ellinghaus, 2020, Genomewide association study of severe Covid-19 with respiratory failure, N Engl J Med Yazer, 2020, Vox Sanguinis International Forum on transfusion services about response to COVID-19, Vox Sang Franchini, 2020, The impact of the SARS-CoV-2 outbreak on the safety and availability of blood transfusions in Italy, Vox Sang, 10.1111/vox.12928 Mohammadi, 2020, Coronavirus disease 2019 (COVID-19) and decrease in blood donation: experience of Iranian Blood Transfusion Organization (IBTO), Vox Sang, 10.1111/vox.12930 Pagano, 2020, Prepare to adapt: blood supply and transfusion support during the first 2 weeks of the 2019 novel coronavirus (COVID-19) pandemic affecting Washington state, Transfusion, 60, 908, 10.1111/trf.15789 Wang, 2020, Impact of COVID-19 on blood centres in Zhejiang province China, Vox Sang, 10.1111/vox.12931 Chang, 2020, Coronavirus disease 2019: coronaviruses and blood safety, Transfus Med Rev, 34, 75, 10.1016/j.tmrv.2020.02.003 Kwon, 2020, Post-donation COVID-19 identification in blood donors, Vox Sang, 10.1111/vox.12925 Wang, 2020, Detection of SARS-CoV-2 in different types of clinical specimens, JAMA, 323, 1843 Huang, 2020, Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China, Lancet, 395, 497, 10.1016/S0140-6736(20)30183-5 Zheng, 2020, Viral load dynamics and disease severity in patients infected with SARS-CoV-2 in Zhejiang province, China, January-March 2020: retrospective cohort study, BMJ, 369 Chang, 2020, Severe acute respiratory syndrome coronavirus 2 RNA detected in blood donations, Emerg Infect Dis, 10.3201/eid2607.200839 Lozada, 2019, The Las Vegas mass shooting: an analysis of blood component administration and blood bank donations, J Trauma Acute Care Surg, 86, 128, 10.1097/TA.0000000000002089 Leung, 2020, Impact of the COVID-19—a regional blood center's perspective, ISBT Science Series, 10.1111/voxs.12558 Tran, 2010, Does donating blood for the first time during a national emergency create a better commitment to donating again?, Vox Sang, 98, e219, 10.1111/j.1423-0410.2009.01274.x Goldman, 2019, Safety of blood donation by individuals over age 70 and their contribution to the blood supply in five developed countries: a BEST Collaborative group study, Transfusion, 59, 1267, 10.1111/trf.15132 Hoad, 2019, Tattoos, blood-borne viruses and blood donors: a blood donor cohort and risk assessment, Vox Sang, 114, 687, 10.1111/vox.12832 Prinsze, 2019, No increased risk of transfusion-transmissible infections after tattooing, body piercing, or acupuncture among blood donors in the Netherlands, Transfusion, 59, 2575, 10.1111/trf.15421 Pillonel, 2020, The evolving blood donor deferral policy for men who have sex with men: impact on the risk of HIV transmission by transfusion in France, Transfusion, 60, 525, 10.1111/trf.15677 Germain, 2020, Men having sex with men and blood donation: is there a game changer on the horizon?, Transfusion, 60, 437, 10.1111/trf.15706 Abolghasemi, 2008, Revisiting blood transfusion preparedness: experience from the Bam earthquake response, Prehosp Disaster Med, 23, 391, 10.1017/S1049023X00006117 Htun, 2020, Responding to the COVID-19 outbreak in Singapore: staff protection and staff temperature and sickness surveillance systems, Clin Infect Dis, 10.1093/cid/ciaa468 Al-Tawfiq, 2018, A multi-faceted approach of a nursing led education in response to MERS-CoV infection, J Infect Public Health, 11, 260, 10.1016/j.jiph.2017.08.006 Gowing, 2017, Disaster preparedness among health professionals and support staff: what is effective? An integrative literature review, Prehosp Disaster Med, 32, 321, 10.1017/S1049023X1700019X Greenhalgh, 2020, Face masks for the public during the covid-19 crisis, BMJ, 369 Brooks, 2019, Protecting the psychological wellbeing of staff exposed to disaster or emergency at work: a qualitative study, BMC Psychol, 7, 78, 10.1186/s40359-019-0360-6 Khalid, 2016, Healthcare workers emotions, perceived stressors and coping strategies during a MERS-CoV outbreak, Clin Med Res, 14, 7, 10.3121/cmr.2016.1303 Farrugia, 2019, The growing importance of achieving national self-sufficiency in immunoglobulin in Italy. The emergence of a national imperative, Blood Transfus, 17, 449 Puig Rovira, 2020, Plasma self-sufficiency in Spain, Transfus Apheresis Sci, 59, 10.1016/j.transci.2019.102700 Young, 2020, Epidemiologic features and clinical course of patients infected with SARS-CoV-2 in Singapore, JAMA, 323, 1488, 10.1001/jama.2020.3204 Shah, 2018, Transfusion of red blood cells stored for shorter versus longer duration for all conditions, Cochrane Database Syst Rev, 12 Trivella, 2019, Can we be certain that storage duration of transfused red blood cells does not affect patient outcomes?, BMJ, 365 Caram-Deelder, 2016, Effect of platelet storage time on platelet measurements: a systematic review and meta-analyses, Vox Sang, 111, 374, 10.1111/vox.12443 MacLennan, 2015, A randomized noninferiority crossover trial of corrected count increments and bleeding in thrombocytopenic hematology patients receiving 2- to 5- versus 6- or 7-day-stored platelets, Transfusion, 55, 1856, 10.1111/trf.13038 McDonald, 2017, Bacterial screening of platelet components by National Health Service Blood and Transplant, an effective risk reduction measure, Transfusion, 57, 1122, 10.1111/trf.14085 Slichter, 2014, Extended storage of buffy coat platelet concentrates in plasma or a platelet additive solution, Transfusion, 54, 2283, 10.1111/trf.12634 Slichter, 2014, Exploratory studies of extended storage of apheresis platelets in a platelet additive solution (PAS), Blood, 123, 271, 10.1182/blood-2013-05-501247 Slichter, 2010, Dose of prophylactic platelet transfusions and prevention of hemorrhage, N Engl J Med, 362, 600, 10.1056/NEJMoa0904084 Stolla, 2018, In vivo viability of extended 4°C-stored autologous apheresis platelets, Transfusion, 58, 2407, 10.1111/trf.14833 Scorer, 2019, Manufacturing variables and hemostatic function of cold-stored platelets: a systematic review of the literature, Transfusion, 59, 2722, 10.1111/trf.15396 Getz, 2016, Storage of platelets at 4°C in platelet additive solutions prevents aggregate formation and preserves platelet functional responses, Transfusion, 56, 1320, 10.1111/trf.13511 Johnson, 2016, Refrigeration and cryopreservation of platelets differentially affect platelet metabolism and function: a comparison with conventional platelet storage conditions, Transfusion, 56, 1807, 10.1111/trf.13630 Braathen, 2019, In vitro quality and platelet function of cold and delayed cold storage of apheresis platelet concentrates in platelet additive solution for 21 days, Transfusion, 59, 2652, 10.1111/trf.15356 Reade, 2019, A randomized, controlled pilot clinical trial of cryopreserved platelets for perioperative surgical bleeding: the CLIP-I trial (Editorial, p. 2759), Transfusion, 59, 2794, 10.1111/trf.15423 Slichter, 2014, Review of in vivo studies of dimethyl sulfoxide cryopreserved platelets, Transfus Med Rev, 28, 212, 10.1016/j.tmrv.2014.09.001 Backholer, 2017, A paired comparison of thawed and liquid plasma, Transfusion, 57, 881, 10.1111/trf.13915 Slichter, 2019, Platelets stored in whole blood at 4°C: in vivo posttransfusion platelet recoveries and survivals and in vitro hemostatic function, Transfusion, 59, 2084, 10.1111/trf.15302 Yazer, 2018, How do I implement a whole blood program for massively bleeding patients?, Transfusion, 58, 622, 10.1111/trf.14474 Bahr, 2020, Practical considerations for a military whole blood program, Mil Med, 10.1093/milmed/usz466 Yazer, 2019, Review of low titre group O whole blood use for massively bleeding patients around the world in 2019, ISBT Sci Ser, 14, 276, 10.1111/voxs.12495 Bjerkvig, 2020, Cold-stored whole blood in a Norwegian emergency helicopter service: an observational study on storage conditions and product quality, Transfusion, 10.1111/trf.15802 Slichter, 2018, Safety and efficacy of cryopreserved platelets in bleeding patients with thrombocytopenia, Transfusion, 58, 2129, 10.1111/trf.14780 Maitland, 2019, Immediate transfusion in African children with uncomplicated severe anemia, N Engl J Med, 381, 407, 10.1056/NEJMoa1900105 Roy, 2020, Protecting vulnerable patients with inherited anaemias from unnecessary death during the COVID-19 pandemic, Br J Haematol, 189, 635, 10.1111/bjh.16687 Hadadi, 2020, Does recombinant human erythropoietin administration in critically ill COVID-19 patients have miraculous therapeutic effects?, J Med Virol, 92, 915, 10.1002/jmv.25839 Stanworth, 2013, A no-prophylaxis platelet-transfusion strategy for hematologic cancers, N Engl J Med, 368, 1771, 10.1056/NEJMoa1212772 Sperry, 2018, Prehospital plasma during air medical transport in trauma patients at risk for hemorrhagic shock, N Engl J Med, 379, 315, 10.1056/NEJMoa1802345 Pusateri, 2019, Association of prehospital plasma transfusion with survival in trauma patients with hemorrhagic shock when transport times are longer than 20 minutes: a post hoc analysis of the PAMPer and COMBAT clinical trials, JAMA Surg, 155 Fabes, 2018, Pro-coagulant haemostatic factors for the prevention and treatment of bleeding in people without haemophilia, Cochrane Database Syst Rev, 12 Dunbar, 2017, Safety of the use of group A plasma in trauma: the STAT study, Transfusion, 57, 1879, 10.1111/trf.14139 Mueller, 2019, Patient blood management: recommendations from the 2018 Frankfurt Consensus Conference, JAMA, 321, 983, 10.1001/jama.2019.0554 Desborough, 2016, Alternatives to allogeneic platelet transfusion, Br J Haematol, 175, 381, 10.1111/bjh.14338 Desborough, 2017, Desmopressin use for minimising perioperative blood transfusion, Cochrane Database Syst Rev, 7 Ljungman, 2020, The challenge of COVID-19 and hematopoietic cell transplantation; EBMT recommendations for management of hematopoietic cell transplant recipients, their donors, and patients undergoing CAR T-cell therapy, Bone Marrow Transplant, 10.1038/s41409-020-0919-0 He, 2020, COVID-19 in persons with haematological cancers, Leukemia, 34, 1637, 10.1038/s41375-020-0836-7 Willan, 2020, Care of haematology patients in a COVID-19 epidemic, Br J Haematol, 189, 241, 10.1111/bjh.16620 Hussain, 2020, COVID-19 infection in patients with sickle cell disease, Br J Haematol, 189, 851, 10.1111/bjh.16734 Nur, 2020, Vaso-occlusive crisis and acute chest syndrome in sickle cell disease due to 2019 novel coronavirus disease (COVID-19), Am J Hematol, 95, 725, 10.1002/ajh.25821 Dexter, 2020, Mitigating the effect of the COVID-19 pandemic on sickle cell disease services in African countries, Lancet Haematol, 7, e430, 10.1016/S2352-3026(20)30122-8 Shander, 2020, The essential role of patient blood management in a pandemic: a call for action, Anesth Analg, 10.1213/ANE.0000000000004844 Murphy, 2013, Transfusing blood safely and appropriately, BMJ, 347, 10.1136/bmj.f4303 Baron, 2020, Patient blood management during the COVID-19 pandemic: a narrative review, Anaesthesia, 10.1111/anae.15095 Doughty, 2020, Triage tool for the rationing of blood for massively bleeding patients during a severe national blood shortage: guidance from the National Blood Transfusion Committee, Brit J Haem, 10.1111/bjh.16736 AminJafari, 2020, The possible of immunotherapy for COVID-19: a systematic review, Int Immunopharmacol, 83, 10.1016/j.intimp.2020.106455 Bloch, 2020, Deployment of convalescent plasma for the prevention and treatment of COVID-19, J Clin Invest, 130, 2757, 10.1172/JCI138745 Maxmen, 2020, How blood from coronavirus survivors might save lives, Nature, 580, 16, 10.1038/d41586-020-00895-8 Wong, 2003, Treatment of severe acute respiratory syndrome with convalescent plasma, Hong Kong Med J, 9, 199 Arabi, 2016, Feasibility of using convalescent plasma immunotherapy for MERS-CoV infection, Saudi Arabia, Emerg Infect Dis, 22, 1554, 10.3201/eid2209.151164 Zhou, 2007, Treatment with convalescent plasma for influenza A (H5N1) infection, N Engl J Med, 357, 1450, 10.1056/NEJMc070359 Sahr, 2017, Evaluation of convalescent whole blood for treating Ebola virus disease in Freetown, Sierra Leone, J Infect, 74, 302, 10.1016/j.jinf.2016.11.009 Mair-Jenkins, 2015, The effectiveness of convalescent plasma and hyperimmune immunoglobulin for the treatment of severe acute respiratory infections of viral etiology: a systematic review and exploratory meta-analysis, J Infect Dis, 211, 80, 10.1093/infdis/jiu396 Duan, 2020, Effectiveness of convalescent plasma therapy in severe COVID-19 patients, Proc Natl Acad Sci USA, 117, 9490, 10.1073/pnas.2004168117 Shen, 2020, Treatment of 5 critically ill patients with COVID-19 with convalescent plasma, JAMA, 323, 1582, 10.1001/jama.2020.4783 Dzik, 2020, COVID-19 convalescent plasma: now is the time for better science, Trans Med Rev, 10.1016/j.tmrv.2020.04.002 Roback, 2020, Convalescent plasma to treat COVID-19: possibilities and challenges, JAMA, 10.1001/jama.2020.4940 Tiberghien, 2020, Collecting and evaluating convalescent plasma for COVID-19 treatment: why and how, Vox Sang, 10.1111/vox.12926 Gandhi, 2020, Asymptomatic transmission, the achilles' heel of current strategies to control Covid-19, N Engl J Med, 382, 2158, 10.1056/NEJMe2009758 Rome, 2020, Drug evaluation during the Covid-19 pandemic, N Engl J Med, 382, 2282, 10.1056/NEJMp2009457